Skip to Main Content

March 20, 2025   
Health Law Daily

FDA Grants Traditional Approval To Pembrolizumab Plus Trastuzumab/Chemo For Patients With PD-L1+, HER2+ Gastric/GEJ Adenocarcinoma

  • March 20, 2025
Share this:

You must be logged in to access this content.

Log in